Fusogenix (IMAGE)

Entos Pharmaceuticals

Fusogenix

Caption

Fusogenix bypasses the endocytic pathway during fusion with the target cell.

Credit

(c) Entos Pharmaceuticals

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.